What is ICUI's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 4.17B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for ICUI?

P/E (TTM) is 137.84 and 52-week range is $113.37 to $192.85 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s ICUI figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for ICUI?

The company profile lists revenue (TTM) near $2.16B, net income (TTM) near $30M, EPS (TTM) near $1.18 when available from the market-data feed. Figures are informational and may lag live markets.

Where is ICU Medical Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in San Clemente, California, US, 25M shares outstanding, ISIN US44930G1076 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

ICU Medical Inc

$ICUI

Health Care · Health Care Equipment & Supplies

IR Run Scenarios

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

ICU Medical, Inc. engages in the provision of innovative medical products used in infusion therapy and critical care applications. The company is headquartered in San Clemente, California and currently employs 13,000 full-time employees. Its product portfolio includes ambulatory, syringe, and large volume intravenous (IV) pumps and safety software, dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, sharps safety products, and sterile IV solutions. Its product offerings also include Consumables, Infusion Systems and Vital Care. Its consumables business unit includes infusion therapy, oncology, vascular access, and tracheostomy products. Its infusion systems offer a portfolio of infusion pumps, software, and professional services. Its vital care business unit includes hemodynamic monitoring, general anesthesia and respiratory, temperature management solutions and regional anesthesia/pain management products. Its infusion therapy products include infusion sets, extension sets, needle-free connectors, and disinfection caps.

Employees

13,000

Website

www.icumed.com/

IPO

1992-03-31

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)